Regeneron Pharmaceuticals
REGN
#235
Rank
NZ$174.25 B
Marketcap
NZ$1,684
Share price
-2.35%
Change (1 day)
34.57%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): NZ$9.99 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are NZ$16.89 Billion. In 2025 the company made an earning of NZ$9.54 Billion, an increase over its 2024 earnings that were of NZ$8.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$9.99 B4.71%
2025 NZ$9.54 B9.43%
2024 NZ$8.71 B13.83%
2023 NZ$7.66 B-13.57%
2022 NZ$8.86 B-47.9%
2021 NZ$17.01 B144.75%
2020 NZ$6.95 B56.86%
2019 NZ$4.43 B-4.87%
2018 NZ$4.65 B22.86%
2017 NZ$3.79 B56.3%
2016 NZ$2.42 B8.55%
2015 NZ$2.23 B54.53%
2014 NZ$1.44 B11.14%
2013 NZ$1.30 B72.13%
2012 NZ$0.75 B-285.93%
2011 -NZ$0.41 Billion121.73%
2010 -NZ$0.19 Billion37.18%
2009 -NZ$0.14 Billion-14.6%
2008 -NZ$0.16 Billion-25.02%
2007 -NZ$0.21 Billion6.32%
2006 -NZ$0.2 Billion-186.52%
2005 NZ$0.22 B2103.7%
2004 NZ$10.29 M-105.66%
2003 -NZ$0.19 Billion-18.18%
2002 -NZ$0.23 Billion42.33%
2001 -NZ$0.16 Billion129.35%
2000 -NZ$68.16 Million51.87%
1999 -NZ$44.88 Million92.19%
1998 -NZ$23.36 Million66.23%
1997 -NZ$14.05 Million-55.49%
1996 -NZ$31.57 Million103.53%
1995 -NZ$15.51 Million-70.89%
1994 -NZ$53.27 Million-26.08%
1993 -NZ$72.06 Million114.67%
1992 -NZ$33.57 Million196.77%
1991 -NZ$11.32 Million87.88%
1990 -NZ$6.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.15 B 229.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$23.06 B 122.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
NZ$20.16 B 94.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$14.20 B 36.95%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$0.81 B-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$2.22 B-78.52%๐Ÿ‡บ๐Ÿ‡ธ USA